Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Sendai virus transgene in a novel gene therapy for laryngotracheal disease.

Mizokami D, Araki K, Tanaka N, Suzuki H, Tomifuji M, Yamashita T, Inoue M, Hasegawa M, Shiotani A.

Laryngoscope. 2013 Jul;123(7):1717-24. doi: 10.1002/lary.23917. Epub 2013 May 10.

PMID:
23666749
2.

Gene therapy of c-myc suppressor FUSE-binding protein-interacting repressor by Sendai virus delivery prevents tracheal stenosis.

Mizokami D, Araki K, Tanaka N, Suzuki H, Tomifuji M, Yamashita T, Ueda Y, Shimada H, Matsushita K, Shiotani A.

PLoS One. 2015 Jan 8;10(1):e0116279. doi: 10.1371/journal.pone.0116279. eCollection 2015.

3.

A defective nontransmissible recombinant Sendai virus mediates efficient gene transfer to airway epithelium in vivo.

Ferrari S, Griesenbach U, Shiraki-Iida T, Shu T, Hironaka T, Hou X, Williams J, Zhu J, Jeffery PK, Geddes DM, Hasegawa M, Alton EW.

Gene Ther. 2004 Nov;11(22):1659-64.

PMID:
15284837
4.

Recombinant Sendai virus vector induces complete remission of established brain tumors through efficient interleukin-2 gene transfer in vaccinated rats.

Iwadate Y, Inoue M, Saegusa T, Tokusumi Y, Kinoh H, Hasegawa M, Tagawa M, Yamaura A, Shimada H.

Clin Cancer Res. 2005 May 15;11(10):3821-7.

5.

Sendai virus-mediated CFTR gene transfer to the airway epithelium.

Ferrari S, Griesenbach U, Iida A, Farley R, Wright AM, Zhu J, Munkonge FM, Smith SN, You J, Ban H, Inoue M, Chan M, Singh C, Verdon B, Argent BE, Wainwright B, Jeffery PK, Geddes DM, Porteous DJ, Hyde SC, Gray MA, Hasegawa M, Alton EW.

Gene Ther. 2007 Oct;14(19):1371-9. Epub 2007 Jun 28.

PMID:
17597790
6.

Airway-directed gene transfer of interleukin-10 using recombinant Sendai virus effectively prevents post-transplant fibrous airway obliteration in mice.

Shoji F, Yonemitsu Y, Okano S, Yoshino I, Nakagawa K, Nakashima Y, Hasegawa M, Sugimachi K, Sueishi K.

Gene Ther. 2003 Feb;10(3):213-8.

PMID:
12571628
7.

Recombinant sendai virus-mediated gene transfer to adipose tissue-derived stem cells (ASCs).

Yukawa H, Noguchi H, Oishi K, Miyazaki T, Kitagawa Y, Inoue M, Hasegawa M, Hayashi S.

Cell Transplant. 2008;17(1-2):43-50.

PMID:
18468234
8.

Newly-developed Sendai virus vector for retinal gene transfer: reduction of innate immune response via deletion of all envelope-related genes.

Murakami Y, Ikeda Y, Yonemitsu Y, Tanaka S, Kondo H, Okano S, Kohno R, Miyazaki M, Inoue M, Hasegawa M, Ishibashi T, Sueishi K.

J Gene Med. 2008 Feb;10(2):165-76.

PMID:
18074401
9.

Expression and maturation of Sendai virus vector-derived CFTR protein: functional and biochemical evidence using a GFP-CFTR fusion protein.

Ban H, Inoue M, Griesenbach U, Munkonge F, Chan M, Iida A, Alton EW, Hasegawa M.

Gene Ther. 2007 Dec;14(24):1688-94. Epub 2007 Sep 27.

PMID:
17898794
10.

Novel treatment for lithium-induced nephrogenic diabetes insipidus rat model using the Sendai-virus vector carrying aquaporin 2 gene.

Suga H, Nagasaki H, Kondo TA, Okajima Y, Suzuki C, Ozaki N, Arima H, Yamamoto T, Ozaki N, Akai M, Sato A, Uozumi N, Inoue M, Hasegawa M, Oiso Y.

Endocrinology. 2008 Nov;149(11):5803-10. doi: 10.1210/en.2007-1806. Epub 2008 Jul 24.

PMID:
18653713
11.

Recombinant Sendai virus vectors deleted in both the matrix and the fusion genes: efficient gene transfer with preferable properties.

Inoue M, Tokusumi Y, Ban H, Shirakura M, Kanaya T, Yoshizaki M, Hironaka T, Nagai Y, Iida A, Hasegawa M.

J Gene Med. 2004 Oct;6(10):1069-81.

PMID:
15386740
12.
13.

Synergistic effect of non-transmissible Sendai virus vector encoding the c-myc suppressor FUSE-binding protein-interacting repressor plus cisplatin in the treatment of malignant pleural mesothelioma.

Kitamura A, Matsushita K, Takiguchi Y, Shimada H, Tada Y, Yamanaka M, Hiroshima K, Tagawa M, Tomonaga T, Matsubara H, Inoue M, Hasegawa M, Sato Y, Levens D, Tatsumi K, Nomura F.

Cancer Sci. 2011 Jul;102(7):1366-73. doi: 10.1111/j.1349-7006.2011.01931.x. Epub 2011 May 9.

14.

Validation of recombinant Sendai virus in a non-natural host model.

Griesenbach U, McLachlan G, Owaki T, Somerton L, Shu T, Baker A, Tennant P, Gordon C, Vrettou C, Baker E, Collie DD, Hasegawa M, Alton EW.

Gene Ther. 2011 Feb;18(2):182-8. doi: 10.1038/gt.2010.131. Epub 2010 Oct 21.

PMID:
20962870
15.

Naked Sendai virus vector lacking all of the envelope-related genes: reduced cytopathogenicity and immunogenicity.

Yoshizaki M, Hironaka T, Iwasaki H, Ban H, Tokusumi Y, Iida A, Nagai Y, Hasegawa M, Inoue M.

J Gene Med. 2006 Sep;8(9):1151-9.

PMID:
16841365
16.

Recombinant sendai virus-mediated gene transfer to mouse pancreatic stem cells.

Oishi K, Noguchi H, Yukawa H, Inoue M, Takagi S, Iwata H, Hasegawa M, Hayashi S.

Cell Transplant. 2009;18(5):573-80.

PMID:
19775519
17.

Recombinant Sendai virus-mediated gene transfer into adult rat retinal tissue: efficient gene transfer by brief exposure.

Ikeda Y, Yonemitsu Y, Sakamoto T, Ishibashi T, Ueno H, Kato A, Nagai Y, Fukumura M, Inomata H, Hasegawa M, Sueishi K.

Exp Eye Res. 2002 Jul;75(1):39-48.

PMID:
12123635
18.

Non-transmissible Sendai virus vector encoding c-myc suppressor FBP-interacting repressor for cancer therapy.

Matsushita K, Shimada H, Ueda Y, Inoue M, Hasegawa M, Tomonaga T, Matsubara H, Nomura F.

World J Gastroenterol. 2014 Apr 21;20(15):4316-28. doi: 10.3748/wjg.v20.i15.4316.

19.

Non-transmissible Sendai virus encoding granulocyte macrophage colony-stimulating factor is a novel and potent vector system for producing autologous tumor vaccines.

Inoue H, Iga M, Nabeta H, Yokoo T, Suehiro Y, Okano S, Inoue M, Kinoh H, Katagiri T, Takayama K, Yonemitsu Y, Hasegawa M, Nakamura Y, Nakanishi Y, Tani K.

Cancer Sci. 2008 Nov;99(11):2315-26. doi: 10.1111/j.1349-7006.2008.00964.x. Epub 2008 Oct 18.

20.

Supplemental Content

Support Center